ホームページ Methylation -Epigenetics SMYD

SMYD

亜型選択性的な製品

SMYD製品

  • All (3)
  • SMYD阻害剤 (3)
  • 新製品
製品コード 製品名称 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S7575 LLY-507 LLY-507 is a cell-active, potent, and selective inhibitor of protein-lysine Methyltransferase SMYD2.
Pharmacol Res, 2022, 177:106122
Oncol Lett, 2020, 20(5):153
J Immunother Cancer, 2019, 7(1):277
S6833 BCI-121 BCI-121 is a potent inhibitor of SMYD3 that impairs the proliferation of many kinds of cancer cells.
Clin Epigenetics, 2023, 15(1):92
Pharmacol Res, 2022, 177:106122
S7042 AZ505 AZ505 is a potent and selective inhibitor of SMYD2 with an IC50 of 0.12 μM.
S7575 LLY-507 LLY-507 is a cell-active, potent, and selective inhibitor of protein-lysine Methyltransferase SMYD2.
Pharmacol Res, 2022, 177:106122
Oncol Lett, 2020, 20(5):153
J Immunother Cancer, 2019, 7(1):277
S6833 BCI-121 BCI-121 is a potent inhibitor of SMYD3 that impairs the proliferation of many kinds of cancer cells.
Clin Epigenetics, 2023, 15(1):92
Pharmacol Res, 2022, 177:106122
S7042 AZ505 AZ505 is a potent and selective inhibitor of SMYD2 with an IC50 of 0.12 μM.

SMYD阻害剤の選択性比較

Tags: SMYD antagonist | SMYD inhibitor | SMYD agonist | SMYD activator